Xiao Zhu

发表

Application of physiologically based pharmacokinetic modelling for the prediction of drug–drug interactions involving anlotinib as a perpetrator of cytochrome P450 enzymes

Mingshe Zhu, Xin'an Wu, Zhiping Jin, 2022, Basic & clinical pharmacology & toxicology.

Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs

Weimin Cai, Z. Jiao, Qingfeng He, 2022, Frontiers in Pharmacology.

Examination of the Impact of CYP3A4/5 on Drug–Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach

Qingfeng He, Xiao Zhu, X. Xiang, 2022, International journal of molecular sciences.

Research and development of Chinese anti-COVID-19 drugs

Yi-min Cui, Qingfeng He, Xiao Zhu, 2022, Acta Pharmaceutica Sinica B.

Network of “drug-target-SARS-CoV-2 Related Genes” Through Integrated Analysis of Pharmacology and Geo Database

Ting-Shou Chen, Xiao Zhu, Jinlan Hou, 2020 .

Applications of In Silico Models to Predict Drug-Induced Liver Injury

Qingfeng He, Xiao Zhu, X. Xiang, 2022, Toxics.

Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling

Qingfeng He, Xiao Zhu, X. Xiang, 2023, International journal of molecular sciences.

Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview

L. Yao, Qingfeng He, Xiao Zhu, 2022, Molecules.

Editorial: Model-informed drug development and evidence-based translational pharmacology

Jinxin Zhao, Yu-Wei Lin, S. Cheung, 2022, Frontiers in Pharmacology.

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

Qingfeng He, Xiao Zhu, X. Xiang, 2022, Frontiers in Pharmacology.

Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.

Naomi L Kruhlak, Xiao Zhu, N. Kruhlak, 2014, Toxicology.

Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model

Weimin Cai, Ke Wang, Ying Chen, 2023, Molecules.

Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae

Yun Li, F. Xue, B. Zheng, 2022, Frontiers in pharmacology.

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir

A. Gwee, Qingfeng He, Xiao Zhu, 2023, Pharmaceutics.

Simultaneous quantification and pharmacokinetics of vincristine and its major metabolite M1 in Chinese pediatric ALL patients by LC-MS/MS

Guoling You, Zhiling Li, Xiao Zhu, 2023, Journal of Pharmaceutical and Biomedical Analysis.

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization

Chuanyue Wang, Qingfeng He, Xiao Zhu, 2023, Frontiers in Pharmacology.

Prediction of Drug–Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model

Qingfeng He, Xiao Zhu, X. Xiang, 2023, Drug Metabolism and Disposition.